<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>ED Antidote & Toxin Dosing Quick Reference</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">

  <link rel="stylesheet" href="/genralPages.css">
  <script src="/script.js"></script>
  <script src="https://kit.fontawesome.com/834304401a.js" crossorigin="anonymous"></script>

  <style>
    body {
      font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;
      font-size: 16px;
      font-weight: bold;
      line-height: 1.8;
      color: #333;
      margin: 0;
      background-color: #eef2f7;
    }

    main {
      padding: 1rem;
      max-width: 900px;
      margin: 0 auto 2rem auto;
    }

    .section-card {
      background: #ffffff;
      border-radius: 12px;
      padding: 1rem 1.25rem;
      margin-bottom: 1rem;
      box-shadow: 0 2px 6px rgba(0, 0, 0, 0.08);
    }

    .page-title {
      font-size: 1.5rem;
      margin: 0 0 0.4rem 0;
      color: #003366;
      text-align: center;
    }

    .page-subtitle {
      font-size: 0.9rem;
      text-align: center;
      color: #555;
      margin-bottom: 0.75rem;
    }

    h2 {
      font-size: 1.15rem;
      margin-top: 0;
      margin-bottom: 0.5rem;
      color: #0066cc;
    }

    h3 {
      font-size: 1rem;
      margin-top: 0.7rem;
      margin-bottom: 0.35rem;
      color: #004c99;
    }

    p {
      margin: 0.3rem 0;
      font-size: 0.9rem;
      line-height: 1.5;
      font-weight: normal;
    }

    .note-text {
      font-size: 0.8rem;
      color: #666;
      font-style: italic;
      margin-top: 0.3rem;
    }

    .pill-note {
      display: inline-block;
      background: #e6f2ff;
      color: #003366;
      padding: 0.25rem 0.6rem;
      border-radius: 999px;
      font-size: 0.8rem;
      margin-bottom: 0.5rem;
    }

    .table-wrapper {
      width: 100%;
      overflow-x: auto;
      margin-top: 0.3rem;
    }

    table {
      border-collapse: collapse;
      width: 100%;
      min-width: 380px;
      font-size: 0.85rem;
    }

    th, td {
      padding: 8px 10px;
      text-align: left;
      border-bottom: 1px solid #ccc;
      vertical-align: top;
      font-weight: normal;
    }

    th {
      background-color: #f2f2f2;
      color: #003366;
      font-weight: 600;
      white-space: nowrap;
    }

    .tag {
      display: inline-block;
      padding: 0.05rem 0.4rem;
      border-radius: 6px;
      font-size: 0.75rem;
      color: #fff;
      margin-right: 0.2rem;
    }

    .tag-critical { background: #cc0000; }
    .tag-important { background: #0066cc; }
    .tag-caution { background: #ff8c00; }

    @media (max-width: 600px) {
      main {
        padding: 0.75rem;
      }

      .section-card {
        padding: 0.85rem 0.9rem;
      }

      .page-title {
        font-size: 1.3rem;
      }

      th, td {
        padding: 7px;
      }
    }
  </style>
</head>
<body>

<header>
  <div class="logo-container">
    <h1 style="color: antiquewhite;">ED Antidote &amp; Toxin Dosing Quick Reference</h1>
    <a href="/index.html" title="Home"><i class="fa-solid fa-house"></i></a>
    <button class="back-button" onclick="goBack()">Back</button>
  </div>
</header>

<main>

  <!-- INTRO -->
  <section class="section-card">
    <h2 class="page-title">Antidote &amp; Toxin Dosing – Quick Ref</h2>
    <p class="page-subtitle">
      Adult dosing guide for time-critical toxicology situations in the ED.
    </p>
    <span class="pill-note">Always confirm with local protocol</span>
    <p class="note-text">
      Doses below are typical adult starting regimens. Adjust for local guidelines, renal/hepatic impairment,
      and patient factors. When in doubt, contact toxicology or a senior.
    </p>
  </section>

  <!-- CORE ANTIDOTES TABLE -->
  <section class="section-card">
    <h2>Key ED Antidotes &amp; Therapies</h2>

    <div class="table-wrapper">
      <table>
        <thead>
        <tr>
          <th>Drug / Therapy</th>
          <th>Indication</th>
          <th>Typical Adult Regimen</th>
          <th>Comments</th>
        </tr>
        </thead>
        <tbody>
        <tr>
          <td><span class="tag tag-critical">Critical</span> N-acetylcysteine (NAC)</td>
          <td>Paracetamol (acetaminophen) overdose</td>
          <td>
            Follow local IV NAC protocol (e.g. staged infusion over 21 h or simplified 2-bag regimen).
          </td>
          <td>
            Start as soon as overdose suspected; use nomogram if time of ingestion known. Watch for anaphylactoid reactions.
          </td>
        </tr>
        <tr>
          <td><span class="tag tag-critical">Critical</span> Naloxone</td>
          <td>Suspected opioid toxicity with respiratory depression</td>
          <td>
            0.04–0.1 mg IV, titrate every 2–3 min to adequate ventilation (up to 2 mg).  
            If no IV access: IM/IN alternatives as per protocol.
          </td>
          <td>
            Aim for adequate respiratory effort, not full wakefulness. Short half-life – consider infusion for long-acting opioids.
          </td>
        </tr>
        <tr>
          <td><span class="tag tag-important">Important</span> Sodium bicarbonate</td>
          <td>TCA toxicity (QRS widening, hypotension), significant salicylate poisoning</td>
          <td>
            TCA: 1–2 mmol/kg IV bolus, repeat as needed, then infusion (e.g. 150 mmol in 1 L D5W).  
            Salicylate: infusion to alkalinise serum &amp; urine.
          </td>
          <td>
            Requires monitoring of pH, sodium, fluid status. Use with senior input.
          </td>
        </tr>
        <tr>
          <td><span class="tag tag-important">Important</span> Atropine</td>
          <td>Organophosphate / carbamate poisoning (cholinergic toxidrome)</td>
          <td>
            1–3 mg IV bolus, then double every 3–5 min until secretions dry &amp; ventilation adequate.  
            May require very large total doses.
          </td>
          <td>
            Target is drying of bronchial secretions, not heart rate alone. Often combined with oxime therapy.
          </td>
        </tr>
        <tr>
          <td>Pralidoxime (2-PAM)</td>
          <td>Organophosphate poisoning (if available)</td>
          <td>
            Example: 30 mg/kg IV over 30 min, then infusion (e.g. 8–10 mg/kg/h), as per local protocol.
          </td>
          <td>
            Works best when given early. Availability varies; follow national guidance.
          </td>
        </tr>
        <tr>
          <td>Hydroxocobalamin</td>
          <td>Suspected cyanide toxicity</td>
          <td>
            5 g IV over 15 min; a second 5 g dose may be given if needed.
          </td>
          <td>
            Can cause red discolouration of skin/urine and interfere with some lab tests.
          </td>
        </tr>
        <tr>
          <td>Calcium gluconate 10% / Calcium chloride</td>
          <td>Hyperkalaemia with ECG changes, CCB toxicity</td>
          <td>
            Hyperkalaemia: 10 mL of 10% calcium gluconate IV over 5–10 min, repeat as needed.  
            CCB toxicity: higher / repeated doses as per protocol, often via central line if calcium chloride used.
          </td>
          <td>
            Stabilises myocardium. Monitor ECG. Avoid extravasation, especially with calcium chloride.
          </td>
        </tr>
        <tr id="hiet">
          <td><span class="tag tag-critical">Critical</span> HIET (High-dose insulin euglycaemic therapy)</td>
          <td>Severe beta-blocker or calcium channel blocker toxicity with shock</td>
          <td>
            Example regimen (confirm locally):  
            • Bolus: 1 unit/kg IV insulin with 25 g IV dextrose (50 mL of 50%)  
            • Infusion: start at 0.5–1 unit/kg/h IV, titrate up (often up to 10 units/kg/h)  
            • Concurrent dextrose infusion to maintain euglycaemia.
          </td>
          <td>
            ICU-level therapy. Requires frequent glucose and potassium monitoring. Combine with vasopressors and calcium as needed.
          </td>
        </tr>
        <tr id="lipid">
          <td><span class="tag tag-important">Important</span> Intravenous lipid emulsion (Intralipid)</td>
          <td>Lipophilic drug toxicity (e.g. local anaesthetic systemic toxicity, some cardio-toxic overdoses)</td>
          <td>
            Example regimen (20% lipid, confirm protocol):  
            • Bolus: 1.5 mL/kg IV over 1 min  
            • Infusion: 0.25 mL/kg/min for 30–60 min  
            • May repeat bolus and increase infusion rate if cardiovascular collapse persists.
          </td>
          <td>
            Reserve for life-threatening toxicity or cardiac arrest due to lipophilic agents. Follow local toxicology guidance.
          </td>
        </tr>
        <tr>
          <td><span class="tag tag-caution">Caution</span> Flumazenil</td>
          <td>Reversal of isolated benzodiazepine sedation in carefully selected patients</td>
          <td>
            0.2 mg IV over 15 s, then 0.1 mg every 60 s as needed (max 1 mg), if used.
          </td>
          <td>
            Avoid in mixed overdoses, seizure disorders, chronic benzo users, or co-ingestion of proconvulsant drugs. Usually specialist-only.
          </td>
        </tr>
        </tbody>
      </table>
    </div>

    <p class="note-text">
      Senior tip: for any complex dosing (NAC, HIET, lipid, cyanide kits), use a calculator or printed protocol at the bedside – these are not drugs to “eyeball”.
    </p>
  </section>

  <!-- LINKS BACK TO MAIN PAGES -->
  <section class="section-card">
    <h2>Related ED Tools</h2>
    <ul>
      <li><a href="/adultresus/toxin.html" class="emphasis-link">Toxins &amp; Antidotes – ED Management</a></li>
      <li><a href="/adultresus/hyperkalaemia.html" class="emphasis-link">Hyperkalaemia Emergency Management</a></li>
    </ul>
  </section>

</main>

</body>
</html>
